Innovation Pharmaceuticals Inc (IPIX)

[CallMeCrazy]

IMO, irrespective of why Leo didn't advance B into a P3, I believe, that as drug resistant infections grow, B will only become more valuable as time goes by.


C auri could drive this trend. As more and more nations have to deal with it, financial incentives should also significantly increase for pharmas to find solutions.


The anti-fungal characteristics of B have been explored but I am unaware of how they might relate to C auri.

. Fungal infections are an area of immense medical need, and the HDP mimetics offer a promising opportunity for the identification of new and effective agents for treatment of these difficult infections.

https://static1.squarespace.com/static/5715352e20c647639137f992/t/583f80229de4bb7e7c4551dd/1480556579601/Antimicrob.-Agents-Chemother.-2014-Ryan-3820-7.pdf

Once upon a time, before this board was taken over by IPIX detractors, posters with medical backgrounds would help the rest of us make sense out of developments such as this, but no sense in longing for days LONG gone by. We're left to our own devices.

Message in reply to:
https://www.msn.com/en-us/health/health-news/deadly-germs-lost-cures-a-mysterious-infection-spanning-the-globe-in-a-climate-of-secrecy/ar-BBVFPi7?li=BBnb7Kz&ocid=mailsignout#page=2